Actively Recruiting
3T MRI in Patients With Deep Brain Stimulation (DBS)
Led by University Health Network, Toronto · Updated on 2024-05-08
250
Participants Needed
1
Research Sites
704 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
Deep brain stimulation (DBS) is an established treatment for advanced Parkinson's disease, medically refractory tremor, dystonia and obsessive compulsive disorder. Several hypotheses driven DBS trials are underway to study modulation of circuit dysfunction in other neurological and psychiatric disorders like epilepsy, Alzheimer's disease and depression. Recent reports suggest profound effects of DBS on the anatomy and function of downstream areas in the brain. For example electrical stimulation of limbic circuits is associated with increase in hippocampal neurogenesis. Similarly, stimulation of subthalamic nucleus (STN) or globus pallidus (GPi) results in activation of cortical motor circuits. Non-invasive imaging modalities are increasingly being employed in these investigations to better understand the effects of DBS on the structure and function of the brain. There have been important advances in MRI and we now have MRI which provides higher resolution and higher quality brain images. More specifically, the investigators propose to use MRI to perform functional magnetic resonance imaging (i.e. fMRI) to assess the effects of deep brain stimulation on brain function and to assess whether fMRI can be used as an adjunct to improve clinical practice in these patients.
CONDITIONS
Official Title
3T MRI in Patients With Deep Brain Stimulation (DBS)
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Age between 18 and 85 years
- Planned to undergo, or have undergone implantation of DBS electrodes
- Able to understand the purpose of the research and sign the informed consent form
- Understand that the study aims to enhance understanding of brain function without direct benefit to the participant
You will not qualify if you...
- Serious cognitive or psychological impairments preventing informed consent
- Inability to communicate effectively, including speech deficits such as dysarthria or aphasia
- Non-English speaking
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Toronto Western Hospital
Toronto, Ontario, Canada, M5T2S8
Actively Recruiting
Research Team
A
Alexandre Boutet, MD/MSc
CONTACT
T
Tasnuva Hoque, BHA
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
NA
Model
SINGLE_GROUP
Primary Purpose
OTHER
Number of Arms
1
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here